# T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/t-cell-responses-to-individualized-neoantigen-therapy-mrna-4157-v940-alone-or-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Justin F. Gainor,Manish R. Patel,Jeffrey S. Weber,Martin Gutierrez,Julie E. Bauman,Jeffrey Clarke,Ricklie Julian,Aaron J. Scott,J.L. Geiger,Kedar Kirtane,Céline Robert-Tissot,Brandon Coder,Moomal Tasneem,Jing Sun,Wei Zheng,Lauren Gerbereux,Andressa S. Laino,Filippos Porichis,Jack Pollard,Peijie Hou,Vasudha Sehgal,Xing Chen,Manju Morrissey,Hikmat N. Daghestani,Igor Feldman,Lakshmi Srinivasan,Joshua P. Frederick,Michelle Brown,Praveen Aanur,Robert Meehan,Howard A. Burris |
| Citations | 104 |
| DOI | 10.1158/2159-8290.cd-24-0158 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4401422221 |
| PMID | 39115419 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Kedar Kirtane](https://scholariq.org/researchers/kedar-kirtane/)

## Paper journal

- [Cancer Discovery](https://scholariq.org/journals/cancer-discovery/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.